CBD brands put on hold as product approvals delayed

CBD oil

The FSA will be unable to recommend authorisations until next year, claimed a source

Already have an account? Sign in here

Want access to this article?

Register for LIMITED access

REGISTER FOR FREE

Get PREMIUM access for £1 a week

SUBSCRIBE NOW